We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CYBG market cap is 22.25B. The company's latest EPS is GBP 0.2916 and P/E is 58.98.
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 1.45B | 1.49B | 1.72B | 1.83B | 1.92B |
| Operating Income | 943M | 1.63B | 1.67B | 1.52B | 1.75B |
| Net Income | -141M | 474M | 537M | 246M | 378M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 90.26B | 89.1B | 91.91B | 91.79B | 89.78B |
| Total Liabilities | 85.33B | 83.63B | 85.57B | 86.18B | 84.3B |
| Total Equity | 4.93B | 5.47B | 6.34B | 5.61B | 5.48B |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 22.25B |
| Price to Earnings Ratio | 58.98 |
| Price to Sales Ratio | 11.6 |
| Price to Cash Ratio | 1.99 |
| Price to Book Ratio | 4.07 |
| Dividend Yield | - |
| Shares Outstanding | 1.3B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.19 (1.12%) |
| Company Name | Ve Bionic Etf |
| Address |
jubilee house newcastle upon tyne NE3 4PL |
| Website | https://www.cybg.com |
| Industry | commercial banks, nec (6029) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
